# Philip Gerretsen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philip-gerretsen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,680 |
| Field | Schizophrenia research and treatment |
| h-index | 39 |
| i10-index | 120 |
| Last Known Institution | Centre for Addiction and Mental Health |
| OpenAlex ID | https://openalex.org/A5017059941 |
| ORCID iD | 0000-0003-4053-6814 |
| Works | 284 |

## Researcher papers

- [Deviant processing of letters and speech sounds as proximate cause of reading failure: a functional magnetic resonance imaging study of dyslexic children](https://scholariq.org/papers/deviant-processing-of-letters-and-speech-sounds-as-proximate-cause-of-reading/)
- [Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis](https://scholariq.org/papers/kynurenic-acid-in-schizophrenia-a-systematic-review-and-meta-analysis/)
- [Individual determinants of COVID-19 vaccine hesitancy](https://scholariq.org/papers/individual-determinants-of-covid-19-vaccine-hesitancy/)
- [Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia](https://scholariq.org/papers/antipsychotics-metabolic-adverse-effects-and-cognitive-function-in-schizophrenia/)
- [Drugs with anticholinergic properties: a current perspective on use and safety](https://scholariq.org/papers/drugs-with-anticholinergic-properties-a-current-perspective-on-use-and-safety/)
- [The potential role of dopamine D3 receptor neurotransmission in cognition](https://scholariq.org/papers/the-potential-role-of-dopamine-d3-receptor-neurotransmission-in-cognition/)
- [Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia](https://scholariq.org/papers/sequential-drug-treatment-algorithm-for-agitation-and-aggression-in-alzheimer-s/)
- [Glutamate-mediated excitotoxicity in schizophrenia: A review](https://scholariq.org/papers/glutamate-mediated-excitotoxicity-in-schizophrenia-a-review/)
- [Insight and medication adherence in schizophrenia: An analysis of the CATIE trial](https://scholariq.org/papers/insight-and-medication-adherence-in-schizophrenia-an-analysis-of-the-catie-trial/)
- [Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study](https://scholariq.org/papers/glutamatergic-neurometabolite-levels-in-patients-with-ultra-treatment-resistant/)
- [Lead (Pb) in Alzheimer’s Dementia: A Systematic Review of Human Case- Control Studies](https://scholariq.org/papers/lead-pb-in-alzheimer-s-dementia-a-systematic-review-of-human-case-control/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Advanced Neuroimaging Techniques and Applications](https://scholariq.org/topics/advanced-neuroimaging-techniques-and-applications/)

## Researcher university

- [Centre for Addiction and Mental Health](https://scholariq.org/institutions/centre-for-addiction-and-mental-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.